Intrafamilial Helicobacter Pylori Infection in Hong Kong
Prevalence and Risk Factors of Intrafamilial Helicobacter Pylori Infection in Hong Kong: a Prospective Cohort Study
1 other identifier
interventional
300
0 countries
N/A
Brief Summary
It is a single-centre, prospective cohort study, which will be conducted in a tertiary academic hospital. The study aims to investigate intrafamilial H. pylori infection status and to identify risk factors for H. pylori infection among household members. The rate of intrafamilial H. pylori spread in Hong Kong is currently unknown. It is also not clear whether the same risk factors for intrafamilial spread of H. pylori infection also apply in Hong Kong. In contrast to mainland China and Taiwan , recent consensus guideline on H. pylori management in Hong Kong in 2023 recommends against routine testing of asymptomatic household members or family members of H. pylori-infected adults. There is a knowledge gap on whether the family-based H. pylori screening is cost effective in our locality. Thus, the investigator aim to investigate infection status of household members of H. pylori infected individuals and risk factors for household infection in Hong Kong. The result from this study will shed light on the role of family-based screening and can inform future healthcare policy making on the strategy of H. pylori management and treatment in Hong Kong, ameliorating H. pylori infection-related disease and gastric cancer burden for society.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
May 22, 2024
CompletedStudy Start
First participant enrolled
June 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2026
ExpectedMay 22, 2024
May 1, 2024
2 years
May 16, 2024
May 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of H. pylori infection in household members
The rate of H. pylori infection in household members of H. pylori infected subjects from the given UBT
during the study period, 2 years
Study Arms (2)
H. pylori positive subjects
NO INTERVENTIONThe H. pylori infected subject is responsible for providing details of the number of household members, family structure, family history of gastric diseases, family economy, living conditions, family hygiene and living habits. Patients also need to provide personal information including HKID, ethnicity.
H. pylori positive subjects' household members
EXPERIMENTALThe household members of the index subjects will be invited to complete a questionnaire which includes the baseline demographics, past medical history, personal hygiene and living habits. Also, they will be received urea beath test (UBT). Referral will be given to those positive result household members.
Interventions
H. pylori infection will be tested using a 13C-urea breath test Kit for all enrolled family members, following the manufacturer's instructions. The sensitivity and specificity of the assay are both over 95%, according to the manufacturer's introduction.
Eligibility Criteria
You may qualify if:
- Adults age\>=18 years of age
- For H. pylori infected patients only: Diagnosed to have H. pylori infection by either histology, rapid urease test or urea breath test
- Written informed consent obtained
You may not qualify if:
- Unable to perform urea breath test
- Contraindications for urea breath test
- Used antibiotics within the past month/proton pump inhibitors within two weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
May 16, 2024
First Posted
May 22, 2024
Study Start
June 11, 2024
Primary Completion
June 10, 2026
Study Completion (Estimated)
December 10, 2026
Last Updated
May 22, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
There will be no plan to share individual participant data.